Teva Pharmaceuticals
About Teva Pharmaceuticals
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Strategic Growth Capital T: - FT: Strategic Growth Capital |
A: 400000000 MR: - FA: 400 million FAN: 400000000 |
D: 2026-03-03 FD: 2026-03-03 |
1 investors |
| 2 |
RT: Debt T: - FT: Debt |
A: 2300000000 MR: - FA: 2,300,000,000 FAN: 2300000000 |
D: 2025-05-20 FD: 2025-05-20 |
- |
| 3 |
RT: Debt T: - FT: Debt |
A: 2000000000 MR: - FA: $2,000,000,000 equivalent FAN: 2000000000 |
D: 2025-05-19 FD: 2025-05-19 |
- |
Growth Metrics
Team & Leadership
Chris Fox
EVP, US Commercial
Sharon Biran
Administrative Professional
Amy Melchior
Medical Writer
Teresa Domagala
Scientific Operations Lead
Virginie Peirs
Senior Director, Regulatory Affairs
Subhajit Goswami
Sr. Director, Manufacturing
Recent News
Teva Pharmaceuticals Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- tevapharm.com
- Industries
- Biopharmaceuticals
- Company Size
- ~1K employees (est.)
- Locations
-
Parsippany, N.J. and Tel Aviv, Israel
TEL AVIV, Israel
Tel Aviv, Israel +4 more
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro